If you're at risk of lymphedema - for instance, if you've recently had cancer surgery involving your lymph nodes - your doctor may diagnose lymphedema based on your signs and symptoms.

Orlando, Florida - Gender disparities exist in clinical practice and academic medicine when it comes to career opportunities and treatment. According to a November 2017 report from the U.S. Bureau of Labor Statistics (BLS), nearly 47 percent of the U.S. workforce are women.  In 2011, the BLS also reported that only 34 percent of physicians and surgeons were women. 

Washington, DC - The U.S. Food and Drug Administration approved Kisqali (ribociclib) in combination with an aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer, as initial endocrine-based therapy. The FDA also approved Kisqali in combination with fulvestrant for the treatment of postmenopausal women with HR-positive, HER2-negative advanced or metastatic breast cancer, as initial endocrine based therapy or following disease progression on endocrine therapy.

Portland, Oregon - The addition of a pharmacist into a team-based care practice model can improve patient outcomes. As key partners in patient care, pharmacists take on a variety of roles, such as helping get a patient’s diabetes or hypertension under control.

A portfolio of joint programs that support a high standard of cardiovascular care for hospitals will help ensure patients have access to the most evidence-based care available. The American Heart Association, the world’s leading voluntary organization dedicated to building healthier lives, free of cardiovascular diseases and stroke, and The Joint Commission, the nation’s largest independent healthcare evaluation organization, are joining forces to provide an unprecedented focus on enhancing cardiovascular patient care through a range of innovative disease-specific hospital certifications while improving outcomes for those hospitalized with cardiovascular conditions, the number one cause of death in the United States.

During active surveillance for prostate cancer, your doctor closely monitors your prostate cancer for any changes. Active surveillance for prostate cancer is sometimes called expectant management or watchful waiting.